| Title | Citalopram-induced bleeding due to severe thrombocytopenia. | | Author(s) | Andersohn F, Konzen C, Bronder E, Klimpel A, Garbe E | | Institution | Institute for Social Medicine, Epidemiology, and Health Economics, Charité University Medical Center, 10098 Berlin, Germany. frank.andersohn@charite.de | | Source | Psychosomatics 2009 May-Jun; 50(3):297-8. | | Abstract | BACKGROUND: In case reports and observational studies, serotonin reuptake-inhibitors (SSRIs) have been linked to an increased risk of bleeding, possibly due to platelet dysfunction as a consequence of serotonin-uptake blockade into platelets.
OBJECTIVE: The authors propose that bleeding as a result of SSRI use may also be caused by other mechanisms.
METHOD: Here, the authors report on a 32-year-old woman with hemorrhages resulting from severe drug-induced immune thrombocytopenia after 4 weeks of citalopram therapy.
RESULTS: After withdrawal of citalopram and treatment with platelet concentrates and prednisolone, the patient recovered completely.
CONCLUSION: As this case report shows, drug-induced immune thrombocytopenia may present another possible mechanism for bleeding in SSRI-treated patients. | | Language | eng | | Pub Type(s) | Journal Article
Research Support, Non-U.S. Gov't
| | PubMed ID | 19567773 |
|
